Skip to main content
Clinical Trials/IRCT20190701044062N2
IRCT20190701044062N2RecruitingPhase 2

Comparison of serum level of vitamin D in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) after administration of Oral & Intramuscular Vit D

Vice chancellor for research, Tabriz University of Medical Sciences0 sites66 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
66

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Adult Patients Over 18 Years With Non-alcoholic Fatty Liver Disease (NAFLD) Based on Diagnosis of Gastroenterologist Osteatogenic drugs
  • vitamin D deficiency (25-hydroxyvitamin D level less than 20 ng / ml), and informed patient consent to participate in the study
  • informed patient consent to participate in the study

Exclusion Criteria

  • Alcohol consumption
  • hereditary history
  • osteogenic drugs
  • metabolic diseases
  • Recent consumption of vitamin D

Investigators

Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences

Similar Trials